Margaret M. Redfield

70.5k total citations · 27 hit papers
415 papers, 44.3k citations indexed

About

Margaret M. Redfield is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Margaret M. Redfield has authored 415 papers receiving a total of 44.3k indexed citations (citations by other indexed papers that have themselves been cited), including 375 papers in Cardiology and Cardiovascular Medicine, 48 papers in Pulmonary and Respiratory Medicine and 46 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Margaret M. Redfield's work include Cardiovascular Function and Risk Factors (254 papers), Heart Failure Treatment and Management (225 papers) and Cardiac pacing and defibrillation studies (71 papers). Margaret M. Redfield is often cited by papers focused on Cardiovascular Function and Risk Factors (254 papers), Heart Failure Treatment and Management (225 papers) and Cardiac pacing and defibrillation studies (71 papers). Margaret M. Redfield collaborates with scholars based in United States, Italy and United Kingdom. Margaret M. Redfield's co-authors include Steven J. Jacobsen, Véronique L. Roger, Richard J. Rodeheffer, Barry A. Borlaug, John C. Burnett, Kent R. Bailey, Douglas W. Mahoney, Carolyn S.P. Lam, Shannon M. Dunlay and David O. Hodge and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Margaret M. Redfield

407 papers receiving 43.2k citations

Hit Papers

Trends in Prevalence and Outcome of Heart Failure with Pr... 1998 2026 2007 2016 2006 2003 2000 2017 2009 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
    2006 3.1k citations Steven J. Jacobsen, Véronique L. Roger et al. New England Journal of Medicine profile →
  2. Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
    2003 2.3k citations Margaret M. Redfield, Steven J. Jacobsen et al. profile →
  3. Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures
    2000 2.2k citations Fletcher A. Miller, Jae K. Oh et al. Circulation profile →
  4. Epidemiology of heart failure with preserved ejection fraction
    2017 996 citations Shannon M. Dunlay, Véronique L. Roger et al. profile →
  5. Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
    2009 987 citations Carolyn S.P. Lam, Véronique L. Roger et al. Journal of the American College of Cardiology profile →
  6. Plasma brain natriuretic peptide concentration: impact of age and gender
    2002 864 citations Margaret M. Redfield, Richard J. Rodeheffer et al. Journal of the American College of Cardiology profile →
  7. Congestive Heart Failure in the Community
    1998 847 citations Richard J. Rodeheffer, Steven J. Jacobsen et al. Circulation profile →
  8. Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
    2010 777 citations Barry A. Borlaug, Rick A. Nishimura et al. Circulation Heart Failure profile →
  9. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction
    2018 704 citations Yogesh N.V. Reddy, Masaru Obokata et al. Circulation profile →
  10. Systolic and Diastolic Heart Failure in the Community
    2006 666 citations Susan A. Weston, Margaret M. Redfield et al. profile →
  11. Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
    2015 630 citations Selma F. Mohammed, Sultan A. Mirzoyev et al. Circulation profile →
  12. Age- and Gender-Related Ventricular-Vascular Stiffening
    2005 620 citations Margaret M. Redfield, Steven J. Jacobsen et al. Circulation profile →
  13. A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010
    2015 568 citations Yariv Gerber, Susan A. Weston et al. profile →
  14. Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction
    2010 523 citations Barry A. Borlaug, Carolyn S.P. Lam et al. Journal of the American College of Cardiology profile →
  15. Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction
    2015 499 citations Michael R. Zile, Margaret M. Redfield et al. Circulation profile →
  16. Progression of Left Ventricular Diastolic Dysfunction and Risk of Heart Failure
    2011 490 citations Garvan C. Kane, Douglas W. Mahoney et al. profile →
  17. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
    2016 475 citations Margaret M. Redfield, Douglas L. Mann et al. profile →
  18. Right heart dysfunction in heart failure with preserved ejection fraction
    2014 462 citations Vojtěch Melenovský, Margaret M. Redfield et al. profile →
  19. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
    2015 370 citations Margaret M. Redfield, Barry A. Borlaug et al. New England Journal of Medicine profile →
  20. Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection Fraction
    2015 369 citations Vojtěch Melenovský, Margaret M. Redfield et al. Circulation Heart Failure profile →
  21. Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
    2014 348 citations Selma F. Mohammed, Imad Hussain et al. Circulation profile →
  22. Heart Failure with Preserved Ejection Fraction
    2016 347 citations Margaret M. Redfield New England Journal of Medicine profile →
  23. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency
    2017 323 citations Gregory D. Lewis, Steven E. McNulty et al. profile →
  24. Heart Failure With Preserved Ejection Fraction
    2023 284 citations Margaret M. Redfield, Barry A. Borlaug profile →
  25. Research Priorities for Heart Failure With Preserved Ejection Fraction
    2020 273 citations Sanjiv J. Shah, Barry A. Borlaug et al. Circulation profile →
  26. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea
    2022 88 citations Yogesh N.V. Reddy, Masaru Obokata et al. profile →
  27. Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting
    2025 14 citations Yogesh N.V. Reddy, Masaru Obokata et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret M. Redfield United States 101 37.9k 6.6k 6.5k 4.8k 4.1k 415 44.3k
Michael R. Zile United States 99 33.1k 0.9× 4.5k 0.7× 3.8k 0.6× 5.1k 1.0× 4.5k 1.1× 575 39.6k
Luigi Tavazzi Italy 105 39.9k 1.1× 4.7k 0.7× 3.5k 0.5× 7.2k 1.5× 3.1k 0.8× 579 47.5k
Barry A. Borlaug United States 92 26.6k 0.7× 6.9k 1.1× 3.9k 0.6× 4.0k 0.8× 1.8k 0.4× 469 31.2k
Richard B. Devereux United States 87 43.0k 1.1× 5.1k 0.8× 12.7k 1.9× 6.5k 1.3× 2.1k 0.5× 353 49.4k
James L. Januzzi United States 100 27.1k 0.7× 6.6k 1.0× 3.3k 0.5× 6.7k 1.4× 3.4k 0.8× 745 39.4k
Mary J. Roman United States 82 28.0k 0.7× 6.3k 1.0× 6.7k 1.0× 5.2k 1.1× 1.6k 0.4× 284 34.6k
Michael H. Picard United States 72 40.7k 1.1× 8.3k 1.3× 13.3k 2.0× 9.1k 1.9× 3.3k 0.8× 361 50.4k
William T. Abraham United States 109 49.4k 1.3× 9.0k 1.4× 2.9k 0.4× 9.5k 2.0× 3.2k 0.8× 692 59.9k
Kent R. Bailey United States 107 33.2k 0.9× 4.6k 0.7× 9.3k 1.4× 8.6k 1.8× 2.6k 0.6× 584 44.1k
Tatiana Kuznetsova Belgium 44 21.1k 0.6× 4.5k 0.7× 5.6k 0.9× 4.2k 0.9× 2.4k 0.6× 284 27.4k

Countries citing papers authored by Margaret M. Redfield

Since Specialization
Citations

This map shows the geographic impact of Margaret M. Redfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret M. Redfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret M. Redfield more than expected).

Fields of papers citing papers by Margaret M. Redfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret M. Redfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret M. Redfield. The network helps show where Margaret M. Redfield may publish in the future.

Co-authorship network of co-authors of Margaret M. Redfield

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret M. Redfield. A scholar is included among the top collaborators of Margaret M. Redfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret M. Redfield. Margaret M. Redfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondo, Toru, Pardeep S. Jhund, Inder S. Anand, et al.. (2025). Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF. JACC Heart Failure. 13(6). 927–939. 2 indexed citations
2.
Harmon, David, et al.. (2025). Valvular Heart Disease and Its Association With Death in Advanced Heart Failure. Journal of the American Heart Association. 14(21). e042875–e042875.
3.
4.
Alogna, Alessio, Katlyn E. Koepp, Michael S. Sabbah, et al.. (2023). Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Failure. 11(11). 1549–1561. 54 indexed citations
5.
Reddy, Yogesh N.V., Gregory D. Lewis, Sanjiv J. Shah, et al.. (2019). Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study. Mayo Clinic Proceedings. 94(7). 1199–1209. 96 indexed citations
6.
Redfield, Margaret M.. (2017). The auther replies. New England Journal of Medicine. 376(9). 8 indexed citations
7.
Reddy, Yogesh N.V., Vojtěch Melenovský, Margaret M. Redfield, Rick A. Nishimura, & Barry A. Borlaug. (2016). High-Output Heart Failure. Journal of the American College of Cardiology. 68(5). 473–482. 194 indexed citations
8.
Saiki, Hirofumi, Benjamin W. Eidem, Tomohito Ohtani, Martha Grogan, & Margaret M. Redfield. (2016). Ventricular‐Arterial Function and Coupling in the Adult Fontan Circulation. Journal of the American Heart Association. 5(9). 34 indexed citations
9.
Mohammed, Selma F., Imad Hussain, Omar F. AbouEzzeddine, et al.. (2014). Right Ventricular Function in Heart Failure With Preserved Ejection Fraction. Circulation. 130(25). 2310–2320. 348 indexed citations breakdown →
10.
Zakeri, Rosita, Alanna M. Chamberlain, Véronique L. Roger, & Margaret M. Redfield. (2013). Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction. Circulation. 128(10). 1085–1093. 274 indexed citations
11.
Chamberlain, Alanna M., Sheila M McNallan, Shannon M. Dunlay, et al.. (2013). Physical Health Status Measures Predict All-Cause Mortality in Patients With Heart Failure. Circulation Heart Failure. 6(4). 669–675. 36 indexed citations
12.
Mohammed, Selma F., Barry A. Borlaug, Véronique L. Roger, et al.. (2012). Comorbidity and Ventricular and Vascular Structure and Function in Heart Failure With Preserved Ejection Fraction. Circulation Heart Failure. 5(6). 710–719. 154 indexed citations
13.
Mirzoyev, Sultan A., William D. Edwards, Selma F. Mohammed, et al.. (2010). Abstract 17926: Cardiac Amyloid Deposition is Common in Elderly Patients with Heart Failure and Preserved Ejection Fraction. Circulation. 122. 61–6. 12 indexed citations
14.
Boilson, Barry A., John A. Schirger, Lucian A. Durham, et al.. (2009). Abstract 3662: Transformation of LVAD Destination Therapy, "Good to Great": Ever Increasing Survival Benefit. Circulation. 120. 3 indexed citations
15.
Dunlay, Shannon M., Yariv Gerber, Susan A. Weston, et al.. (2009). Prognostic Value of Biomarkers in Heart Failure. Circulation Heart Failure. 2(5). 393–400. 46 indexed citations
16.
Lam, Carolyn S.P., Barry A. Borlaug, Garvan C. Kane, et al.. (2009). Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population. Circulation. 119(20). 2663–2670. 314 indexed citations
17.
Lam, Carolyn S.P., Barry A. Borlaug, Garvan C. Kane, Richard J. Rodeheffer, & Margaret M. Redfield. (2008). Abstract 6206: Age-Associated Increases in Pulmonary Artery Systolic Pressure in the General Population. Circulation. 118. 1128–1134. 1 indexed citations
18.
Krüger, Martina, Sebastian Kötter, Patrick Lang, et al.. (2008). Protein Kinase G Modulates Human Myocardial Passive Stiffness by Phosphorylation of the Titin Springs. Circulation Research. 104(1). 87–94. 328 indexed citations
19.
Miyazaki, Chinami, Brian D. Powell, Charles J. Bruce, et al.. (2008). Comparison of Echocardiographic Dyssynchrony Assessment by Tissue Velocity and Strain Imaging in Subjects With or Without Systolic Dysfunction and With or Without Left Bundle-Branch Block. Circulation. 117(20). 2617–2625. 85 indexed citations
20.
Ammar, Khawaja Afzal, Steven J. Jacobsen, Douglas W. Mahoney, et al.. (2007). Prevalence and Prognostic Significance of Heart Failure Stages. Circulation. 115(12). 1563–1570. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael R. Zile Breakdown of academic impact, for papers by Luigi Tavazzi Breakdown of academic impact, for papers by Barry A. Borlaug Breakdown of academic impact, for papers by Richard B. Devereux Breakdown of academic impact, for papers by James L. Januzzi Breakdown of academic impact, for papers by Mary J. Roman Breakdown of academic impact, for papers by Michael H. Picard Breakdown of academic impact, for papers by William T. Abraham Breakdown of academic impact, for papers by Kent R. Bailey Breakdown of academic impact, for papers by Tatiana Kuznetsova
Rankless by CCL
2026